Castleman’s disease is a rare group of disorders that causes the immune system to remain constantly activated, leading to swollen lymph nodes and potentially serious organ damage throughout the body.

Prognosis

Understanding what to expect with Castleman’s disease is important, though the outlook varies greatly depending on which type you have. This can be a difficult topic, but knowing the possibilities helps you and your loved ones prepare and make informed decisions about care.

For people with unicentric Castleman disease, which means the condition affects only one lymph node or one area of lymph nodes, the prognosis is generally favorable. Surgery to remove the affected lymph node is usually curative, meaning once the enlarged lymph node is completely removed and any previous abnormalities return to normal, the person is considered cured. People with unicentric Castleman disease usually do well once the affected lymph node is removed, and life expectancy is typically not changed.^[10]

The outlook for multicentric Castleman disease, where multiple regions of lymph nodes are affected throughout the body, is more complex and varies by subtype. Historically, the five-year overall survival rate for multicentric Castleman disease ranged from fifty-five percent to seventy-seven percent.^[13] However, advances in treatment, particularly with newer biologic agents, have significantly improved survival rates in recent years.

For people with HHV-8-associated multicentric Castleman disease, treatment with rituximab is highly effective, offering good control of the condition when combined with appropriate antiviral therapy for those who also have HIV.^[10] The prognosis for idiopathic multicentric Castleman disease depends on the severity of symptoms and response to treatment. The introduction of siltuximab, the first FDA-approved treatment for this form, has provided hope, with patients who respond to this medication tending to have long-term responses.^[10]

A particularly serious subtype called iMCD-TAFRO is known to be the most severe form of idiopathic multicentric Castleman disease.^[2] This form can be life-threatening if not treated promptly and appropriately, as it involves severe complications including very low platelet counts, fluid accumulation throughout the body, fever, kidney dysfunction, and enlarged organs.

Natural Progression

If Castleman’s disease is left untreated, its natural progression differs significantly between the types. Understanding how the disease develops without intervention helps explain why early diagnosis and treatment are so crucial.

In unicentric Castleman disease, many people may not experience symptoms at all, with enlarged lymph nodes being the only sign of the condition. However, as the affected lymph node continues to grow over time, it may eventually create pressure on nearby organs, leading to discomfort or complications depending on its location. For example, an enlarged lymph node in the chest might press against airways or blood vessels, while one in the abdomen could affect digestion or other abdominal organs.^[1] Without surgical removal, the mass may remain stable for years but could continue to enlarge slowly.

The natural course of multicentric Castleman disease without treatment is far more concerning. Because this form involves an overactive immune system that produces excessive amounts of inflammatory proteins called cytokines (chemical messengers that signal the immune system to activate), the body experiences what can be described as a constant “cytokine storm.”^[13] This ongoing inflammation affects multiple organ systems simultaneously.

As multicentric Castleman disease progresses untreated, lymph nodes in various parts of the body continue to enlarge. The excessive cytokine production leads to persistent flu-like symptoms including fever, night sweats, fatigue, and unintended weight loss. More seriously, vital organs begin to malfunction. The liver and spleen can become enlarged and unable to perform their normal functions. The bone marrow, which produces blood cells, becomes impaired, leading to anemia (low red blood cells causing fatigue), low platelet counts (increasing bleeding risk), and other blood abnormalities.^[14]

The kidneys may begin to fail, unable to filter waste products from the blood effectively. Fluid accumulates in the body, causing swelling in the legs, ankles, and sometimes throughout the body. Without intervention, this multi-organ dysfunction can become life-threatening. The immune system dysfunction may also increase susceptibility to infections, and some patients may develop other serious complications affecting the nervous system, skin, or blood vessels.^[1]

In a study examining patients with asymptomatic HHV-8-negative multicentric Castleman disease, transformation to symptomatic disease occurred in about five percent of patients after a median of twenty-eight and a half months.^[12] This suggests that even when the disease appears quiet initially, it can become active over time, emphasizing the importance of monitoring even in seemingly mild cases.

Possible Complications

Castleman’s disease can lead to various complications that extend beyond the primary symptoms of enlarged lymph nodes and inflammation. These complications can affect multiple organ systems and sometimes develop unexpectedly, making regular monitoring essential.

One of the most serious complications seen primarily in multicentric Castleman disease is organ dysfunction or failure. The liver can become so enlarged and damaged that it cannot properly process toxins, produce proteins needed for blood clotting, or perform its many other vital functions. Similarly, the spleen may become massively enlarged, a condition called splenomegaly, which can cause it to trap and destroy blood cells prematurely, worsening anemia and low platelet counts.^[1]

Kidney complications are particularly concerning in the TAFRO subtype of idiopathic multicentric Castleman disease. Kidney function can deteriorate rapidly, sometimes requiring dialysis. The kidneys may be unable to remove waste products and excess fluid from the blood, leading to dangerous imbalances in body chemistry.^[1]

Blood-related complications are common in multicentric Castleman disease. Anemia, a condition where there are too few red blood cells to carry oxygen throughout the body, causes severe fatigue and weakness. Thrombocytopenia, or low platelet counts, increases the risk of bleeding and bruising. Some patients develop abnormal levels of proteins in their blood, including excessive antibodies, which can lead to blood becoming too thick or cause kidney damage.^[1]

Peripheral neuropathy, which causes numbness, tingling, or pain in the hands and feet, can occur, particularly in patients with POEMS-associated multicentric Castleman disease. This happens when excessive inflammatory proteins damage the nerves that carry signals between the brain and the rest of the body.^[1]

Fluid accumulation represents another significant complication. Anasarca, which means swelling throughout the body due to fluid buildup, can occur in severe cases, particularly in iMCD-TAFRO. Fluid may also accumulate in the chest cavity around the lungs or in the abdomen, making breathing difficult and causing discomfort.^[13]

Some patients develop increased susceptibility to infections due to immune system dysfunction. Despite the immune system being overactive in some ways, it may not function properly in fighting actual infections, leaving patients vulnerable to bacterial, viral, or fungal diseases.

There is also a concerning relationship between Castleman’s disease and the development of other serious conditions. Some patients may develop lymphoma, a type of blood cancer, though this risk varies by subtype. Additionally, as mentioned earlier, people with unicentric Castleman disease face a small but significant risk of developing paraneoplastic pemphigus, a potentially deadly autoimmune skin condition.^[10]

Impact on Daily Life

Living with Castleman’s disease affects nearly every aspect of daily life, from physical activities to emotional wellbeing, work responsibilities, and social relationships. The extent of these impacts depends largely on which type of the disease you have and how well it responds to treatment.

For those with unicentric Castleman disease, daily life impact may be minimal, especially after successful surgical removal of the affected lymph node. Many people return to their normal activities without significant limitations. However, before diagnosis and treatment, an enlarged lymph node in certain locations might cause discomfort or limitations. For instance, a mass in the chest might make deep breathing uncomfortable, while one in the abdomen could cause digestive symptoms or discomfort with certain movements.^[1]

Multicentric Castleman disease typically has a much more profound impact on daily functioning. The persistent fatigue that many patients experience can be overwhelming, making it difficult to complete even basic daily tasks. Unlike normal tiredness that improves with rest, this fatigue is often relentless and can leave you feeling exhausted even after a full night’s sleep. Simple activities like showering, preparing meals, or walking short distances may require considerable effort and frequent rest breaks.^[1]

Fever and night sweats, common symptoms in multicentric disease, disrupt sleep quality, leading to further exhaustion during the day. You might wake up multiple times during the night drenched in sweat, needing to change clothes and bedding. This sleep disruption creates a cycle where fatigue worsens, making concentration difficult and affecting memory and decision-making abilities.

Nausea, vomiting, and loss of appetite can make eating challenging, leading to unintended weight loss and nutritional deficiencies. Mealtimes may become stressful rather than enjoyable, and the social aspects of sharing meals with family or friends may be affected. Some patients find they can only tolerate small amounts of certain foods, requiring careful meal planning throughout the day.^[20]

Physical activities and exercise often need to be modified or reduced. The combination of fatigue, shortness of breath from anemia, and general weakness can make exercise difficult. However, complete inactivity can worsen symptoms, creating a difficult balance. Many patients find they need to pace themselves carefully, alternating between activity and rest, and adjusting their activity levels based on how they feel each day.

Work life frequently requires adjustments. You may need to reduce working hours, shift to less physically demanding tasks, or take extended medical leave during flare-ups or intensive treatment periods. The unpredictability of symptoms can make maintaining a regular work schedule challenging. Some people find they need to explain their condition to employers and coworkers to gain understanding and flexibility, though explaining a rare disease that many people have never heard of can be frustrating.

Social life and relationships may suffer as well. When you’re dealing with persistent symptoms, social activities that once brought joy may feel like burdensome obligations. Declining invitations repeatedly can lead to feelings of isolation, and friends who don’t understand the invisible nature of your illness may struggle to comprehend why you can’t participate as before. Some people with Castleman’s disease report feeling misunderstood or having their symptoms minimized by others who see them looking “fine” on the outside.

Emotional and mental health impacts are significant and should not be underestimated. Living with a rare disease that many doctors have never encountered can create feelings of isolation and anxiety. Worrying about disease progression, treatment effectiveness, and long-term prognosis adds psychological burden. Some patients experience depression related to their diagnosis, loss of previous capabilities, and uncertainty about the future.^[20]

For those requiring ongoing treatments such as infusions of biologic medications, medical appointments become a regular part of life. These treatments may require several hours in an infusion center every few weeks, disrupting work and personal schedules. The treatments themselves may cause side effects that affect daily functioning, requiring additional adjustments.

Financial impacts can be substantial. Medical expenses, including diagnostic procedures, treatments, hospitalizations, and ongoing monitoring, can be significant even with insurance. Lost work time or the need to reduce working hours affects income. Some patients need to hire help for household tasks they can no longer manage independently.

Support for Family

When someone in your family has Castleman’s disease, it affects everyone. Understanding the disease, knowing what to expect, and learning how you can help are essential for both supporting your loved one and maintaining your own wellbeing during this challenging time.

Family members should first educate themselves about Castleman’s disease, particularly the specific subtype affecting their loved one. Because this is a rare condition, many healthcare providers have limited experience with it, and family members may find themselves needing to advocate alongside the patient. Understanding the difference between unicentric and multicentric types, knowing what symptoms to watch for, and learning about available treatments helps family members participate meaningfully in care decisions and medical appointments.^[18]

Clinical trials represent an important avenue for accessing cutting-edge treatments and contributing to medical knowledge about Castleman’s disease. Because the condition is rare and much remains unknown about optimal treatment approaches, clinical trials play a crucial role in advancing care. Family members can help by researching available clinical trials with their loved one. The Castleman Disease Collaborative Network maintains information about ongoing clinical trials specifically for Castleman’s disease patients. Discussing clinical trial options with the patient’s medical team can help determine whether participation might be beneficial.^[18]

When considering clinical trial participation, families should understand what involvement entails. Clinical trials may require additional medical visits, specific testing schedules, and detailed record-keeping. Family members can assist by helping track appointments, recording symptoms, and providing transportation to trial sites, which may sometimes be located far from home. It’s important to discuss as a family the potential benefits and burdens of trial participation, considering both the possible advantages of accessing new treatments and the additional time and energy commitments required.

Families can support their loved one in preparing for clinical trial participation by helping gather complete medical records, compile lists of all current medications and supplements, and document symptom patterns. Many trials have specific eligibility criteria, and having organized medical information readily available can streamline the screening process. Family members can also help ensure the patient understands informed consent documents and feels comfortable asking questions about the trial protocol.^[16]

Beyond clinical trials, family support in daily life is invaluable. Understanding that fatigue in Castleman’s disease is not ordinary tiredness but a profound exhaustion helps family members have realistic expectations. Your loved one isn’t being lazy or unmotivated—they’re dealing with a disease that drains their energy. Offering to help with household tasks, grocery shopping, meal preparation, or childcare can significantly reduce their burden.

Accompanying the patient to medical appointments provides both practical and emotional support. Having another person present helps ensure important information isn’t missed, questions are remembered and asked, and complex treatment discussions are better understood. Family members can take notes during appointments, allowing the patient to focus on the conversation with their doctor. After appointments, discussing what was said helps ensure everyone understands the care plan.

Emotional support is equally important as practical help. Living with a rare disease can be isolating and frightening. Simply being present, listening without trying to fix everything, and acknowledging the difficulty of what your loved one is experiencing provides tremendous comfort. Avoid minimizing their symptoms or comparing their situation to others. Phrases like “at least it’s not cancer” or “you don’t look sick” can be hurtful, even when well-intentioned.

Family members should also recognize that patients may experience grief over lost abilities, changed life plans, and uncertainty about the future. Supporting them through these emotions, perhaps by suggesting professional counseling when needed, helps address the psychological impacts of the disease.

Connecting with resources specifically designed for Castleman’s disease patients and families can be extremely helpful. The Castleman Disease Collaborative Network offers extensive resources, including educational materials, support communities, and connections to experienced medical experts. Encouraging your loved one to join patient registries like the ACCELERATE registry contributes to research while potentially providing access to additional resources and information.^[18]

Family caregivers must also attend to their own wellbeing. Caring for someone with a chronic illness can be physically and emotionally draining. Seeking support for yourself, whether through counseling, caregiver support groups, or respite care, isn’t selfish—it’s necessary. You can’t provide effective support if you’re exhausted and depleted yourself.

Financial planning and insurance navigation often fall partially on family members. Understanding insurance coverage for treatments, particularly newer biologic medications that can be expensive, and exploring financial assistance programs can ease the financial burden. Some pharmaceutical companies offer patient assistance programs for their medications, and nonprofit organizations may provide additional support.

Finally, families should maintain hope while being realistic. Advances in understanding and treating Castleman’s disease are being made through ongoing research. Organizations like the Castleman Disease Collaborative Network are actively working to accelerate discoveries and improve outcomes. By supporting your loved one through their journey and potentially participating in research efforts, you’re contributing to a larger effort that may help countless others facing this rare disease in the future.^[16]